John F. Milligan, Director at 4D Molecular Therapeutics Inc. (FDMT), bought 100,000 shares at $23.00 ($2.3M) on 2020-12-15, disclosed to the SEC on 2020-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| GILD | SELL | 2016-08-03 | $5.0M | — | Filing → |
| GILD | SELL | 2016-07-07 | $18.9M | — | Filing → |
| GILD | SELL | 2016-06-08 | $19.5M | — | Filing → |